Yu Nakanishi
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Rapidly Progressive Diffuse Alveolar Damage Following Transbronchial Lung Biopsy in a Patient with Lung Adenocarcinoma: An Autopsy Case Report.
Journal: Internal medicine (Tokyo, Japan)
Published: August 03, 2026
New-onset Anti-melanoma Differentiation-associated Gene 5 Antibody Positive Clinically Amyopathic Dermatomyositis Following COVID-19.
Journal: Internal medicine (Tokyo, Japan)
Published: December 10, 2025
Allergic Bronchopulmonary Mycosis Caused by Nigroporus vinosus.
Journal: Internal medicine (Tokyo, Japan)
Published: August 20, 2025
Anti-OJ Antibody-positive Antisynthetase Myopathy Diagnosed after Pulmonary Embolization.
Journal: Internal medicine (Tokyo, Japan)
Published: November 10, 2024
Association Between Patient Preference for Inhaler Medications and Asthma Outcomes.
Journal: Journal of asthma and allergy
Published: July 12, 2022
IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis.
Journal: PloS one
Published: November 16, 2020
Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis.
Journal: Internal medicine (Tokyo, Japan)
Published: June 26, 2020
Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer.
Journal: International journal of clinical oncology
Published: May 15, 2019
Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer.
Journal: Respiratory investigation
Published: January 15, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026